Senate Bill No. 518, introduced by Senators Alvord and West, amends the existing medical marijuana packaging and labeling requirements under 63 O.S. 2021, Section 427.18. The bill mandates that medical marijuana products must be packaged in a way that minimizes their appeal to children and prohibits the use of images that could attract individuals under the age of 21. Additionally, it introduces new labeling requirements, including specific warnings that must be included on the product labels, such as advisories against driving under the influence of marijuana, warnings for pregnant women, and confirmation that the product has been tested for contaminants.

The bill also specifies that any medical marijuana product that does not meet these packaging and labeling standards must be returned to the supplier or disposed of properly. Furthermore, it empowers the Executive Director of the Oklahoma Medical Marijuana Authority to establish minimum standards for packaging and labeling, which will include essential information such as THC potency and product warnings. The act is set to take effect on November 1, 2025.

Statutes affected:
Introduced: 63-427.18
House Committee Substitute for Senate Bill: 63-427.18
Floor (House): 63-427.18
Floor (Senate): 63-427.18
Engrossed: 63-427.18
Amended And Engrossed: 63-427.18
Enrolled (final version): 63-427.18
Sub Committee OR Policy Committee Recommendations (House) Policy Committee Recommendation: 63-427.18